Advertisement

Pulmonology

Home Pulmonology
In the United States

Severe COVID-19 Risk Up With Existing Health Conditions in U.S.

Most commonly reported underlying health conditions were diabetes, chronic lung disease, CVD

October 2016 Briefing – Pulmonology

Here are what the editors at HealthDay consider to be the most important developments in Pulmonology for October 2016. This roundup includes the latest...
From 1990 to 2016

Nonsmoker Mortality Showcases Harm of Secondhand Smoke

One nonsmoker dies from secondhand tobacco smoke exposure for every 52 smokers
Cancer patients who have diabetes may suffer worse heart damage from chemotherapy

Chemo-Related Cardiotoxicity Worse in Diabetes Patients

Those with diabetes showed more early warning signs of heart failure

ACIP Recommends PCV15 for Children Younger Than 19 Years

PCV15 includes two serotypes in addition to those in the PCV13 vaccine, and is recommended according to PCV13 dosing and schedules

Radiation oncology expert Stephen Hahn

Dr. Stephen Hahn Nominated to Head FDA

Hahn is chief medical executive of The University of Texas MD Anderson Cancer Center in Houston
Strong demand for medications that show promise as treatments for COVID-19 have led to shortages of those drugs in the United States.

Shortages Seen for Drugs That Show Promise Against COVID-19

Patients who currently rely on remdesivir or hydroxychloroquine now facing dangerous shortages
Men and women have different cardiovascular reactivity mechanisms for mental stress-induced myocardial ischemia

Gender Differences Seen in Mental Stress-Induced Ischemia

CV reactivity mechanisms for mental stress-induced myocardial ischemia different for men, woman
The U.S. government will pay Johnson & Johnson $1 billion for 100 million doses of its vaccine if it is approved by the U.S. Food and Drug Administration

Johnson & Johnson Makes $1 Billion Vaccine Deal

Company has said it will offer doses at a not-for-profit cost to provide global access to the vaccine
A shipment of baby powder has been recalled by Johnson & Johnson after U.S. authorities found asbestos in it.

Johnson & Johnson Recalls Baby Powder Due to Presence of Asbestos

This is the first time Johnson & Johnson has pulled its baby powder from the market